These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32100040)

  • 1. Cocaine and depressive disorders: When standard clinical diagnosis is insufficient.
    Alías-Ferri M; García-Marchena N; Mestre-Pintó JI; Araos P; Vergara-Moragues E; Fonseca F; González-Saiz F; Rodríguez de Fonseca F; Torrens M; Group N
    Adicciones; 2021 Jul; 33(3):193-200. PubMed ID: 32100040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
    García-Marchena N; Barrera M; Mestre-Pintó JI; Araos P; Serrano A; Pérez-Mañá C; Papaseit E; Fonseca F; Ruiz JJ; Rodríguez de Fonseca F; Farré M; Pavón FJ; Torrens M
    PLoS One; 2019; 14(3):e0213791. PubMed ID: 30870525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder.
    Galván ST; Flores-López M; Romero-Sanchiz P; Requena-Ocaña N; Porras-Perales O; Nogueira-Arjona R; Mayoral F; Araos P; Serrano A; Muga R; Pavón FJ; García-Marchena N; de Fonseca FR
    Sci Rep; 2021 Jul; 11(1):13629. PubMed ID: 34211033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression.
    Fonseca F; Mestre-Pinto JI; Rodríguez-Minguela R; Papaseit E; Pérez-Mañá C; Langohr K; Barbuti M; Farré M; Torrens M;
    Front Psychiatry; 2022; 13():836771. PubMed ID: 35370811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up.
    Nunes EV; Liu X; Samet S; Matseoane K; Hasin D
    J Clin Psychiatry; 2006 Oct; 67(10):1561-7. PubMed ID: 17107247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study.
    de Azevedo Cardoso T; Jansen K; Mondin TC; Pedrotti Moreira F; de Lima Bach S; da Silva RA; de Mattos Souza LD; Balanzá-Martínez V; Frey BN; Kapczinski F
    Psychiatry Clin Neurosci; 2020 Aug; 74(8):418-423. PubMed ID: 32306467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of adolescent substance use and depressive symptoms with adult major depressive disorder in the United States: NSDUH 2016-2019.
    Xu C; Wang S; Su BB; Ozuna K; Mao C; Dai Z; Wang K
    J Affect Disord; 2024 Jan; 344():397-406. PubMed ID: 37844780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.
    Pavón FJ; Araos P; Pastor A; Calado M; Pedraz M; Campos-Cloute R; Ruiz JJ; Serrano A; Blanco E; Rivera P; Suárez J; Romero-Cuevas M; Pujadas M; Vergara-Moragues E; Gornemann I; Torrens M; de la Torre R; Rodríguez de Fonseca F
    Addict Biol; 2013 Nov; 18(6):955-69. PubMed ID: 24283982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample.
    Pacek LR; Martins SS; Crum RM
    J Affect Disord; 2013 Jun; 148(2-3):188-95. PubMed ID: 23260381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder.
    Requena-Ocaña N; Flores-López M; García-Marchena N; Pavón-Morón FJ; Pedraza C; Wallace A; Castilla-Ortega E; Rodríguez de Fonseca F; Serrano A; Araos P
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I
    Keller B; Mestre-Pinto JI; Álvaro-Bartolomé M; Martinez-Sanvisens D; Farre M; García-Fuster MJ; García-Sevilla JA; Torrens M;
    Front Psychiatry; 2017; 8():258. PubMed ID: 29326609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of major depression on remission and relapse of substance dependence.
    Hasin D; Liu X; Nunes E; McCloud S; Samet S; Endicott J
    Arch Gen Psychiatry; 2002 Apr; 59(4):375-80. PubMed ID: 11926938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
    Davis LL; Rush JA; Wisniewski SR; Rice K; Cassano P; Jewell ME; Biggs MM; Shores-Wilson K; Balasubramani GK; Husain MM; Quitkin FM; McGrath PJ
    Compr Psychiatry; 2005; 46(2):81-9. PubMed ID: 15723023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipolar features in major depressive disorder: Results from the Iranian mental health survey (IranMHS).
    Amin-Esmaeili M; Motevalian A; Rahimi-Movaghar A; Hajebi A; Sharifi V; Mojtabai R; Gudarzi SS
    J Affect Disord; 2018 Dec; 241():319-324. PubMed ID: 30142591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
    J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of comorbid mental disorders on time to seeking treatment for major depressive disorder.
    Olfson M; Liu SM; Grant BF; Blanco C
    Med Care; 2012 Mar; 50(3):227-32. PubMed ID: 22186769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent versus substance-induced major depressive disorders in first-admission patients with substance use disorders: an exploratory study.
    Langås AM; Malt UF; Opjordsmoen S
    J Affect Disord; 2013 Jan; 144(3):279-83. PubMed ID: 23158758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
    Gonzalez G; Feingold A; Oliveto A; Gonsai K; Kosten TR
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):497-514. PubMed ID: 14510037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tryptophan System in Cocaine-Induced Depression.
    Fonseca F; Mestre-Pintó JI; Gómez-Gómez À; Martinez-Sanvisens D; Rodríguez-Minguela R; Papaseit E; Pérez-Mañá C; Langohr K; Valverde O; Pozo ÓJ; Farré M; Torrens M; On Behalf Of Neurodep Group
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33352710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.